Decline in NRF2-regulated Antioxidants in Chronic Obstructive Pulmonary Disease Lungs Due to Loss of Its Positive Regulator, DJ-1
Deepti Malhotra(Bloomberg (United States)), Shyam Biswal(Johns Hopkins University), Xiaoxi Zhuang(University of Chicago), Rubin M. Tuder(University of Colorado Denver), Ana Navas‐Acién(Johns Hopkins University), Linan Chen(The George Institute for Global Health), James C. Hogg(University of British Columbia), Mark Elliott(University of British Columbia), Anju Singh(University of Alabama at Birmingham), Rajesh K. Thimmulappa(Johns Hopkins University), Peter D. Paré(University of British Columbia), Andrew J. Sandford(University of British Columbia)
Cited by 354
Related Papers
Social Determinants of Health and Diabetes: A Scientific Review
|Diabetes Care|2020|1.6k
Lead Exposure and Cardiovascular Disease—A Systematic Review
|Environmental Health Perspectives|2006|1.1k
Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
|PLoS Medicine|2006|1k
Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis
|Journal of Clinical Investigation|2006|1k
Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke–induced emphysema in mice
|Journal of Clinical Investigation|2004|879